Valerio Therapeutics Announces Signing of Definitive Agreements for the buyout of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors Business Wire
Source: news.google.com